Price T Rowe Associates Inc Astrazeneca PLC Call Options Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$54.02 - $63.83 $756,280 - $893,620
-14,000 Reduced 59.57%
9,500 $524,000
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $127,788 - $139,817
2,300 Added 10.85%
23,500 $1.41 Million
Q2 2021

Aug 16, 2021
BUY
$48.42 - $60.18 $1.03 Million - $1.28 Million
21,200 New
21,200 $1.27 Million

Others Institutions Holding AZN

# of Institutions
1,414
Shares Held
499M
Call Options Held
7.24M
Put Options Held
2.65M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email